James P. Flynn, Member of the Firm and Managing Shareholder of the firm’s Newark office, was quoted in Massachusetts Lawyers Weekly, in “Federal Judge Weighs Anti-SLAPP ‘Burden,’” by Kris Olson. The article discusses Mr. Flynn’s work on behalf of client, Hi-Tech Pharmaceuticals. (Read the full version – subscription required.)
Following is an excerpt:
Hi-Tech Pharmaceuticals’ attorney, James P. Flynn of Newark, New Jersey, said he and his co-counsel “did not see Steinmetz as driving the analysis” in their case.
Flynn argued in his brief that Steinmetz “simply supports the same observation made in earlier cases … that there are similarities between the Maine Anti-SLAPP statute … and the Massachusetts Anti-SLAPP statute.”
Moreover, Flynn noted that while Casper alternately dismissed Steinmetz’s claims under Fed. R. Civ. P. 12(b)(6), his client had survived such a motion.
“This is important because Massachusetts and Maine law make clear that the anti-SLAPP statute is not intended to allow for the dismissal of meritorious claims,” he argued.
People
Managing Director / Member of the Firm
